{"id":"W2145161475","doi":"10.1016/s0140-6736(12)60986-6","title":"Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Daiichi-Sankyo; Daiichi Sankyo Company; Regado Biosciences; Medicines Company; CSL Behring; GlaxoSmithKline; Eli Lilly and Company","keywords":"Apixaban; Medicine; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine; Embolism; Randomized controlled trial; Clinical endpoint; Rivaroxaban; Cardiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009078995,0.004566608,0.01224653,0.001287379,0.00106123,0.003680269,0.002198254,0.004152736,0.008730957],"category_scores_gemma":[0.0171874,0.002014359,0.01341341,0.001485395,0.002571771,0.00301738,0.001354621,0.00649187,0.001150402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001601501,"about_ca_system_score_gemma":0.001522014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00198962,"about_ca_topic_score_gemma":0.00219664,"domain_scores_codex":[0.990032,0.005962652,0.001164744,0.001597108,0.0006340595,0.0006094772],"domain_scores_gemma":[0.9859136,0.007505994,0.003045088,0.001656085,0.0007802018,0.001099146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9897642,0.000540763,0.0006839944,0.0006899197,0.006479219,0.00002059754,0.00003049448,0.0001085738,0.0002490094,0.00005435145,0.0001491929,0.001229666],"study_design_scores_gemma":[0.9746361,0.01193708,0.002877856,0.00006436429,0.009431561,0.00003013812,0.00002371407,0.0003748286,0.0001271982,0.000263029,0.0001987398,0.00003538259],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9709821,0.01459828,0.001920394,0.0009530787,0.001704353,0.003911796,0.003122277,0.0002003323,0.002607378],"genre_scores_gemma":[0.9857259,0.003101472,0.001809061,0.0009358907,0.00131457,0.003593525,0.001819463,0.00006109873,0.001639087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01224653,"threshold_uncertainty_score":0.04801488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0400351424776182,"score_gpt":0.3079300448470321,"score_spread":0.2678949023694139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}